[1]
S. Walia and P. Varma, “Bevacizumab (Avastin) for Ocular Disorders”, Int J of Pharmc Res, vol. 3, no. 4, pp. 59–68, Dec. 2013, doi: 10.7439/ijpr.v3i4.55.